Publications by authors named "Nikos Gavalas"

Claim this Profile
E
Editorial: Current trends and future prospects in the use of immunotherapy in ovarian cancer.
Nikos G Gavalas

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group.
Charalampos Fragkoulis, Aristotelis Bamias, Nikos Gavalas, Kimon Tzannis, Evangelos Fragiadis

Eur Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group.
Aristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, Roubini Zakopoulou, Kimon Tzannis

Curr Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer.
Dimitra T Stefanou, Aristotelis Bamias, Hara Episkopou, Soterios A Kyrtopoulos, Maria Likka, Nikos Gavalas

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical Properties of Magnetic Nanoparticles: Implications for Biomedical Applications In Vitro and In Vivo.
Anna A Belanova, Nikos Gavalas, Yuriy M Makarenko, Mariya M Belousova, Alexander V Soldatov

Oncol Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.
Sofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G Gavalas, Kimon Tzannis, Olga Papadodima

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.
Dimitra T Stefanou, Aristotelis Bamias, Hara Episkopou, Soterios A Kyrtopoulos, Maria Likka, Nikos Gavalas

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis-related pathways in the pathogenesis of ovarian cancer.
Nikos G Gavalas, Michalis Liontos, Sofia-Paraskevi Trachana, Tina Bagratuni, Calliope Arapinis

Int J Mol Sci· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2.
Apostolos C Ziogas, Nikos G Gavalas, Marinos Tsiatas, Ourania Tsitsilonis, Ekaterini Politi

Int J Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.
Nikos G Gavalas, Alexandra Karadimou, Meletios A Dimopoulos, Aristotelis Bamias

Clin Dev Immunol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of human autoantibody binding sites on the calcium-sensing receptor.
E Helen Kemp, Nikos G Gavalas, Samia Akhtar, Kai J E Krohn, J Carl Pallais

J Bone Miner Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult.
Marinella Tzanela, Dimitra Zianni, Kalliopi Bilariki, Alexandros Vezalis, Nikos Gavalas

Eur J Endocrinol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.
E Helen Kemp, Nikos G Gavalas, Kai J E Krohn, Edward M Brown, Philip F Watson

J Clin Endocrinol Metab· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies.
Nikos G Gavalas, Raju V S R K Gottumukkala, David J Gawkrodger, Philip F Watson, Anthony P Weetman

Exp Dermatol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.
Nikos G Gavalas, E Helen Kemp, Kai J E Krohn, Edward M Brown, Philip F Watson

J Clin Endocrinol Metab· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
E Helen Kemp, Nikos G Gavalas, David J Gawkrodger, Anthony P Weetman

Autoimmun Rev· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients.
Raju V S R K Gottumukkala, Nikos G Gavalas, Samia Akhtar, Russell A Metcalfe, David J Gawkrodger

Lab Invest· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
Nikos G Gavalas, Samia Akhtar, David J Gawkrodger, Philip F Watson, Anthony P Weetman

Biochem Biophys Res Commun· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population.
Samia Akhtar, Nikos G Gavalas, David J Gawkrodger, Philip F Watson, Anthony P Weetman

Arch Dermatol Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis